| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
NovoCure Limited (NASDAQ: NVCR)
NVCR Technical Analysis
5
| As on 9th Jun 2023 NVCR STOCK Price closed @ 42.76 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 75.81 & Strong Sell for SHORT-TERM with Stoploss of 73.95 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NVCRSTOCK Price
| Open | 45.54 | Change | Price | % |
| High | 45.61 | 1 Day | -2.74 | -6.02 |
| Low | 42.00 | 1 Week | -29.05 | -40.45 |
| Close | 42.76 | 1 Month | -22.83 | -34.81 |
| Volume | 4008400 | 1 Year | -42.30 | -49.73 |
| 52 Week High 118.81 | 52 Week Low 47.00 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| NVCR Daily Charts |
NVCR Intraday Charts |
Whats New @ Bazaartrend |
NVCR Free Analysis |
|
|
NVCR Important Levels Intraday
| RESISTANCE | 49.72 |
| RESISTANCE | 47.49 |
| RESISTANCE | 46.11 |
| RESISTANCE | 44.73 |
| SUPPORT | 40.79 |
| SUPPORT | 39.41 |
| SUPPORT | 38.03 |
| SUPPORT | 35.80 |
NVCR Forecast May 2024
| 4th UP Forecast | 91.46 |
| 3rd UP Forecast | 75.84 |
| 2nd UP Forecast | 66.19 |
| 1st UP Forecast | 56.53 |
| 1st DOWN Forecast | 28.99 |
| 2nd DOWN Forecast | 19.33 |
| 3rd DOWN Forecast | 9.68 |
| 4th DOWN Forecast | -5.94 |
NVCR Weekly Forecast
| 4th UP Forecast | 61.28 |
| 3rd UP Forecast | 55.34 |
| 2nd UP Forecast | 51.67 |
| 1st UP Forecast | 48.00 |
| 1st DOWN Forecast | 37.52 |
| 2nd DOWN Forecast | 33.85 |
| 3rd DOWN Forecast | 30.18 |
| 4th DOWN Forecast | 24.24 |
NVCR Forecast2024
| 4th UP Forecast | 193.12 |
| 3rd UP Forecast | 144.9 |
| 2nd UP Forecast | 115.09 |
| 1st UP Forecast | 85.29 |
| 1st DOWN Forecast | 0.23 |
| 2nd DOWN Forecast | -29.57 |
| 3rd DOWN Forecast | -59.38 |
| 4th DOWN Forecast | -107.6 |
NovoCure Limited ( NASDAQ USA Symbol : NVCR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NVCR Business Profile
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. The company markets Optune and Optune Lua, a Tumor Treating Fields delivery system for use as a monotherapy treatment for adult patients with glioblastoma. It is also developing products for brain metastases, non-small cell lung cancer, pancreatic cancer, gastric cancer, ovarian cancer, liver cancer, and mesothelioma. The company markets its products in the European Union, Japan, and internationally. It has a clinical trial collaboration agreement with MSD to evaluate tumor treating fields together with KEYTRUDA, an anti-PD-1 therapy; and a strategic alliance with the NYU Grossman School of Medicine's Department of Radiation Oncology that provides a framework for preclinical and clinical development projects studying Tumor Treating Fields. NovoCure Limited was founded in 2000 and is based in Saint Helier, Jersey. Address: No. 4 The Forum, Saint Helier, Jersey, JE2 4UF
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service